Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients

Corneal Staining Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00518700
• Other study ID #: 5321
• Status: Completed
• Phase: Phase 4
• First received: August 17, 2007
• Last updated: April 21, 2008
• Est. completion date: April 2008

Study information

• Verified date: April 2008
• Source: Innovative Medical
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

To compare corneal staining after contact lens instillation with a new MPS vs. RepleniSH

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: April 2008
• Est. primary completion date: April 2008
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Patients 18 yrs or older

2. Males or females

3. Any race or ethnic background

4. CL patients using MPS products currently

5. Patients using Contact Lenses habitually (at least 1 month)

Exclusion Criteria:

1. Corneal refractive surgery within 6 months of this study.

2. Contact lens use on day of examination.

3. Corneal ectasia.

4. Current use of Restasis

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Investigator)

Related Conditions & MeSH terms

• Corneal Staining

Intervention

Other:
• new MPS

• RepleniSH

Locations

Country	Name	City	State
United States	Private Practice	Azusa	California

Sponsors (1)

Lead Sponsor	Collaborator
Innovative Medical

Country where clinical trial is conducted

United States,